Here's Why Point72's Steve Cohen's Bought Millions Worth of Biotech Stocks Last Week
New York Mets owner and billionaire investor Steve Cohen purchased two biotech stocks last week, one being a new addition to Point 72's portfolio.
International Business Times UK ·